68 completed, 7 unknown, 3 terminated, 3 withdrawn. 34 Not applicable, 20 Phase 2, 10 Phase 3, 9 Phase 1, 6 Phase 4.
Follow Hyperhidrosis: new trials by email Literature Review of Hyperhidrosis trials Research Report on Hyperhidrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 20% Alcohol With Steroid Local Anesthetic Technique Versus Steroid Local Anesthetic Technique Only in Stellate Ganglion Injection in Idiopathic Palmar Hyperhydrosis Group A, Group B - Hyperhidrosis | Not applicable | Not yet recruiting | Fayoum University Hospital | 50 | 2026-09-01 | 2026-08-26 |
| "Incidence of Compensatory Hyperhidrosis After T3 Vs T3-4 Sympathectomy" Compensatory Hyperhidrosis, Compensatory Sweating | Not yet recruiting | Assiut University | 46 | 2025-11-15 | 2025-10-03 | |
| Treatment and Mapping of Impostor Phenomenon Impostor tasks - Dermatoses, Vestibulodynia | Not applicable | Unknown | Umeå University | 20 | 2024-05-15 | 2024-05-10 |
| Severe Primary Hand Hyperhidrosis Treatment With Topical Administration of Victorhy TTB gel (dose 1), TTB gel (dose 2), Placebo - Palmar Hyperhidrosis | Phase 2 | Terminated | Dryox Health | 58 | 2024-04-29 | 2025-06-22 |
| Outcome Of Bilateral Thoracoscopic Sympathectomy for Patients With Primary Focal Hyperhidrosis Thoracic Sympathectomy - Hyperhidrosis Primary Focal Palms | Not applicable | Recruiting | Sohag University | 100 | 2024-01-01 | 2024-10-15 |
| Methotrexate Iontophoresis Versus Coal Tar Ointement in the Treatment of Primary Palmer Hyper Hidrosis Iontophoresis with methotrexate, Iontophoresis with coal tar ointement - Hyperhidrosis, Iontophore | Not applicable | Unknown | Cairo University | 60 | 2023-06-01 | 2023-05-25 |
| Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis. - Hyperhidrosis Primary Focal Axilla | Not applicable | Unknown | InMode MD Ltd. | 70 | 2023-03-09 | 2024-01-12 |
| Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis Glycopyrronium Bromide (GPB) Cream - Primary Axillary Hyperhidrosis | Phase 2 | Completed | Dr. August Wolff GmbH & Co. KG Arzneimittel | 44 | 2023-03-07 | 2024-04-04 |
| Assessment of the Rate of Oseointegration Surrounding Nano-coated Orthodontic Titanium Miniscrew Blank group, Silver hydroxyapatite, Zinc oxide - Health Care Utilization, Diet, Healthy | Not applicable | Completed | Al-Azhar University | 18 | 2023-01-01 | 2024-09-03 |
| miraDry Post Market Tumescent Anesthesia Study miraDry treatment - Hyperhidrosis, Axillary Hyperhidrosis | Not applicable | Withdrawn | miraDry, Inc. | 2022-11-01 | 2023-10-23 | |
| Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? Topical oxybutynin spray, Topical placebo spray, Oral oxybutynin - Hyperhidrosis, Oxybutynin | Phase 2 | Unknown | Samantha Rodrigues Camargo Neves de Moura | 17 | 2022-09-26 | 2024-05-28 |
| Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18 Thoracoscopic sympathectomy, Thoracoscopic sympathotomy, Thoracoscopic sympathetic chain clipping - Hyperhidrosis, Children, Adolescents | Not applicable | Completed | dr. Muhammad Abdelhafez Mahmoud, MD | 420 | 2022-09-01 | 2023-11-02 |
| Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users Topical antiperspirant - Hyperhidrosis, Residual Limbs | Not applicable | Completed | Sophies Minde Ortopedi | 7 | 2022-08-09 | 2023-04-13 |
| Targeting Nociceptors in Hidradenitis Suppurativa Botulinum toxin - Hidradenitis Suppurativa, Hyperhidrosis | Recruiting | University of Massachusetts, Worcester | 20 | 2022-06-07 | 2026-09-10 | |
| Qbrexza Cloths for Hyperhidrosis of Amputation Sites glycopyrronium cloths, Placebo - Amputation, Hyperhidrosis | Phase 2 | Completed | University of Utah | 13 | 2021-09-27 | 2026-01-22 |
| Determination of Longus Colli Muscle Thickness by Ultrasonography Pain Syndrome, Pain, Intractable | Completed | Istanbul University | 200 | 2021-03-01 | 2022-10-03 | |
| Laser Acupuncture Versus Tap Water Iontophoresis on Hyperhidrosis Laser Acupoint, Tap water iontophoresis - Hyperhidrosis | Not applicable | Completed | Kafrelsheikh University | 40 | 2021-02-01 | 2021-09-16 |
| An Open Label Study for Palmar Hyperhydrosis Glycopyrronium 2.4 % Medicated Cloth - Palmar Hyperhidrosis, Hyperhidrosis | Phase 2 | Completed | Pariser, Robert J., M.D. | 120 | 2020-10-01 | 2021-05-28 |
| Implementation of a Minor Ailment Service in Community Pharmacy Practice Minor ailment service - Acne, Bites | Not applicable | Completed | Universidad de Granada | 20987 | 2020-10-01 | 2023-12-07 |
| Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis miraDry® - Axillary Hyperhidrosis | Not applicable | Completed | Region Östergötland | 100 | 2020-09-04 | 2023-12-29 |
Showing 20 of 85. Sign in to see all of them.
Skin Diseases (6) · Sweat Gland Diseases (6) · Sweating, Gustatory (3) · Body Odor (2) · Depression (2) · Somatoform Disorders (2) · Acne Vulgaris (1) · Autonomic Nervous System Diseases (1) · Bites and Stings (1) · Burns (1) · Candidiasis, Vulvovaginal (1) · Common Cold (1) · Complex Regional Pain Syndromes (1) · Constipation (1)
Skin and Connective Tissue Diseases (85) · Skin Diseases (79) · Sweat Gland Diseases (79) · Nervous System Diseases (8) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (6) · Autonomic Nervous System Diseases (4) · Mental Disorders (4) · Neurologic Manifestations (4) · Behavior (3) · Pain (3) · Pathologic Processes (3) · Bacterial Infections and Mycoses (2) · Behavioral Symptoms (2) · Female Urogenital Diseases (2)
Botulinum Toxins, Type A (14) · oxybutynin (9) · Glycopyrrolate (5) · Aluminum Chloride (3) · Cholinergic Antagonists (2) · GSK573719 (2) · Vacuum Curettage (2) · glycopyrronium tosylate (2) · rimabotulinumtoxinB (2) · 2-methylcyclopentadienyl manganese tricarbonyl (1) · Antiperspirants (1) · Blood Cell Count (1) · Bone Morphogenetic Proteins (1) · Botulinum Toxins (1) · Cosmetics (1)
Allergan (5) · Botanix Pharmaceuticals (5) · Journey Medical Corporation (5) · Dr. August Wolff GmbH & Co. KG Arzneimittel (4) · Cynosure, Inc. (3) · GlaxoSmithKline (3) · Ulthera, Inc (3) · University of Sao Paulo (3) · University of Utah (3) · Miramar Labs (2) · Northwestern University (2) · Thomas Jefferson University (2) · Al-Azhar University (1) · Assiut University (1) · Atacama Therapeutics (1)
United States (41) · Brazil (7) · Egypt (7) · Germany (6) · Canada (5) · Sweden (4) · Spain (3) · France (2) · South Korea (2) · Denmark (1) · Israel (1) · Japan (1) · Lebanon (1) · Netherlands (1) · Norway (1)
Lynne M Deans, MT (3) · Patricia Krantz (3) · Colby Hansen, MD (2) · Mark Nestor, MD, PhD (2) · Patricia Walker, MD PhD (2) · Rajnish Mago, MD (2) · Alejandra Onate, M.S. (1) · Altair S Costa Jr, MD (1) · Anna L Bruckner, MD (1) · Atef M Sayed, MD (1) · Carl Swartling, MD, PhD (1) · Chih-ho Hong, MD (1)
PMID 31111409, PMID 26114588, PMID 30378087, PMID 32147881, PMID 33433785, PMID 13845515, PMID 14759407, PMID 15280848, PMID 18557587, PMID 19233423, PMID 19797095, PMID 20626389, PMID 21963104, PMID 22341836, PMID 23167161, PMID 23638448, PMID 24519200, PMID 26059781, PMID 27427529, PMID 27889103, PMID 36130719, PMID 37151084, PMID 37280417
2015 (3), 2014 (1), 2023 (1), K08AR080844 (1), UL1TR001082 (1)